— Leading Specialty CDMO Partners with AcuteBio, LLC to Create a Breakthrough 505(b)(2) Nanomedicine to Improve Acute Care Treatment Modalities with a Gold Standard Medication — NORTH BRUNSWICK, N.J., June 27, 2023 /PRNewswire/ — Ascendia Pharmaceuticals CEO Jim Huang, Ph.D. announces…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.